OR WAIT null SECS
May 18, 2023
ProBioGen’s Lenti.RiGHT is a lentivirus production platform for use in gene transfer applications.
ChargePoint Technology and Famat Sampling’s combination technology is designed to allow for product sampling during the course of production.
Sania Therapeutics has emerged from stealth mode and launched its technology platforms for enabling the development of novel therapeutics to treat neural circuit dysfunction.
Gilead Sciences and Arcus Biosciences have expanded their research collaboration to include inflammatory diseases in addition to oncology.
May 17, 2023
Astellas and Sony will collaborate to discover a novel ADC platform for use in oncology.
May 16, 2023
Under the collaboration, BiOneCure Therapeutics and Nanjing Leads Biolabs intend to develop a range of innovative antibody-drug conjugates for treating solid tumors.
May 15, 2023
Advanced continuous manufacturing with modular components is emerging as a preferred platform to produce APIs.
May 12, 2023
In a deal potentially worth more than $530 million, Amgen will use TScan Therapeutics’ target discovery platform to home in on novel targets for Crohn’s disease treatment.
The new partnership between Sandoz, a Novartis division, and Just – Evotec Biologics will aim to develop and manufacture multiple biosimilars.
May 10, 2023
Private investors from Advent International and Warburg Pincus will operate the assets as an independent CDMO.